Gastroenterology

Monika Fischer, MD, talks about focusing research on patients with more severe IBD symptoms at 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Monika Fischer, MD, discusses the outcomes of a study assessing fecal microbiota transplantation for c. difficile infection at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

In morbidly obese but otherwise morbidly obese patients who had bariatric surgery, cardiovascular, and metabolic improvements were noted after 12 months.

Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.

Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Study results show that eluxadoline may be useful in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) who do not achieve symptom relief with loperamide.

Charles Bernstein, MD, FACG, discusses his research on Inflammatory Bowel Disease (IBD) treatment at the 2014 ACG Annual Meeting in Philadelphia, PA.

Study results show significant regional variations in the types of procedures and tests administered and the number of prescriptions written for patients with irritable bowel syndrome (IBS), as well as in the number of emergency department visits and hospital admissions.

John Saltzman, MD, Director of Endoscopy, Brigham and Women's Hospital, shares his experiences and thoughts on endoscopy testing and other topics discussed at the 2014 ACG Annual Meeting in Philadelphia, PA.

John Saltzman, MD, discusses the gastrointestinal tract and the integration of novel gastrointestinal procedures into treatment, and the role of the human microbiome in relation to GI disorders.

In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?

Interim study results presented at ACG 2014 indicate that treatment with vedolizumab safely and effectively maintains long-term clinical remission and response in patients with Crohn's disease and ulcerative colitis.

Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.

Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.

The incidence of young-onset colorectal cancer is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American College of Gastroenterology, held from Oct. 17 to 22 in Philadelphia.

A new clinical trial in children is set to begin that will test the blockbuster hepatitis C drug Sovaldi in combination with ribavirin as part of an all-oral regimen.

The US FDA last week approved the combo drug (trade name: Harvoni) for use in the US.

Researchers are looking for the next best non-invasive and safe alternatives to fight infections. Although unconventional, a preliminary study published in the Journal of the American Medical Association revealed the successful strides researchers have made to cure patients suffering from recurrent C. Difficile infection (CDI) using oral frozen fecal matter treatment.

In treatment-naive patients with genotype 4 HCV, treatment with daclatasvir in combination with peginterferon alfa/ribavirin resulted in higher SVR12 rates than treatment with peginterferon alfa/ribavirin alone.

Researchers in Barcelona, Spain, have recently developed a fruit fly, Drosophila melanogaster, with colon cancer that aids in identifying significant genetic factors within human intestinal cancer.

Uceris (budesonide) is now approved in a new dose for the induction of remission in patients afflicted with active mild-to-moderate distal ulcerative colitis.

A Canadian research team has discovered a rare disease named Chronic Atrial Intestinal Dysrhythmia syndrome (CAID) caused by a unique genetic mutation that affects both intestinal tract and heart rates.

Scientists in Germany have discovered a causal relationship between psychological factors and symptoms of irritable bowel syndrome (IBS) after viewing high rates of anxiety and depression among IBS patients.

Patients of Indian ancestry living in the United States are at greater risk for all types of inflammatory bowel disease (IBD) than other American populations, according to a new study by Reenu Malhotra, MD, and colleagues published online in Clinical Gastroenterology and Hepatology on July 29, 2014.

Clostridium difficile (C. diff) infection is now the leading cause of infectious nosocomial diarrhea in the industrialized world. But by following Infectious Disease Society of America (IDSA) treatment guidelines, clinicians can significantly reduce recurrence and mortality, a Texas Tech University Health Sciences Center School of Pharmacy team reports.

Kevin Skole, MD is a board-certified gastroenterologist practicing in central New Jersey, part of the gastroenterology division of Princeton Healthcare Affiliated Physicians, a multi-specialty medical practice based out of the University Medical Center of Princeton at Plainsboro (see www.princetonhcs.org). He discusses the increased incidence, risk factors, and prevention of Clostridium Difficile (C. diff) infection.

There is a wide variety of evidence to support benefits of low-fat diets versus low carbohydrate diets and vice versa. As of today, no one can tell us with certainty whether the well-worn dictum "calories in calories out" is really true. The National Weight Control Registry data give us some confidence in recommending that to lose weight most people need to alter their diet to reduce calories, and need to exercise on a near-daily basis.

Study results show that treatment with a proton pump inhibitor does not reduce the effectiveness of metformin treatment in patients with type 2 diabetes.

As more practices and hospitals enter the digital age with Electronic Health Records (EHR) and other health information technology tools, a recent article points out that all those efforts are only half the battle.

Implementation of Massachusetts health care reform reduced all-cause mortality and mortality from causes amenable to health care